Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Country | Year | All substitution clients | Year | All treatment demand clients (TDI) | Year | Total number of clients in treatment (ST24) | Estimation of total number of clients in treatment | Total adult population (15-64 ys) in 2010 | ||
---|---|---|---|---|---|---|---|---|---|---|
Belgium | (i) | 2010 | 17 622 | 2010 | 5 366 | 2010 | 5 366 | 17 622 | 7 147 512 | |
Bulgaria | (ii) | 2010 | 3 012 | 2010 | 1 573 | 2010 | 4 400 | (1) | 4 400 | 5 211 619 |
Czech Republic | (ii) | 2010 | 5 900 | 2010 | 8 484 | 2009 | 16 343 | (2) | 16 343 | 7 413 560 |
Denmark | (ii) | 2010 | 7 515 | 2010 | 5 337 | 2010 | 11 119 | 11 119 | 3 630 561 | |
Germany | (ii) | 2010 | 77 400 | 2010 | 71 507 | 2010 | 164 804 | (3) | 164 804 | 53 877 881 |
Estonia | (i) | 2010 | 1 064 | 2010 | 665 | : | : | 1 064 | 908 466 | |
Ireland | (ii) | 2010 | 8 727 | 2010 | 8 511 | 2010 | 17 238 | (4) | 17 238 | 3 008 292 |
Greece | (ii) | 2010 | 6 264 | 2010 | 5 645 | 2010 | 8 602 | (5) | 8 602 | 7 539 573 |
Spain | (ii) | 2009 | 78 311 | 2010 | 52 549 | 2010 | 182 698 | 182 698 | 31 371 220 | |
France | (i) | 2010 | 145 000 | 2010 | 46 606 | 2010 | 96 700 | (6) | 145 000 | 41 966 225 |
Italy | (ii) | 2010 | 103 564 | 2010 | 56 146 | 2010 | 176 430 | (7) | 176 430 | 39 655 921 |
Cyprus | (ii) | 2010 | 294 | 2010 | 767 | 2010 | 884 | (8) | 884 | 562 662 |
Latvia | (iii) | 2010 | 237 | 2010 | 1 738 | 2010 | 1 738 | (9) | 1 738 | 1 549 011 |
Lithuania | (i) | 2010 | 904 | 2010 | 328 | 2010 | 523 | 904 | 2 295 339 | |
Luxembourg | (i) | 2010 | 1 248 | 2010 | 230 | : | : | 1 248 | 342 909 | |
Hungary | (ii) | 2010 | 1 031 | 2010 | 4 543 | 2009 | 6 917 | (10) | 6 917 | 6 873 985 |
Malta | (iii) | 2010 | 1 119 | 2010 | 1 936 | 2010 | 1 875 | 1 936 | 288 538 | |
Netherlands | (ii) | 2010 | 10 085 | 2010 | 12 919 | 2010 | 35 943 | 35 943 | 11 123 750 | |
Austria | (ii) | 2010 | 14 962 | 2010 | 5 271 | 2007 | 16 726 | 16 726 | 5 654 499 | |
Poland | (iii) | 2010 | 2 114 | 2010 | 14 408 | 2010 | 11 341 | (11) | 14 408 | 27 223 082 |
Portugal | (ii) | 2010 | 29 325 | 2010 | 5 179 | 2010 | 37 983 | (12) | 37 983 | 7 119 943 |
Romania | (iii) | 2010 | 601 | 2010 | 2 163 | 2010 | 2 163 | (13) | 2 163 | 15 003 660 |
Slovenia | (i) | 2010 | 3 545 | 2010 | 797 | 2010 | 3 332 | (14) | 3 545 | 1 421 436 |
Slovakia | (iii) | 2010 | 610 | 2010 | 2 266 | 2010 | 2 226 | 2 266 | 3 928 471 | |
Finland | (i) | 2009 | 1 800 | 2010 | 1 364 | : | : | 1 800 | 3 552 663 | |
Sweden | (iii) | 2007 | 3 115 | 2010 | 6 424 | : | : | 6 424 | 6 100 463 | |
UK- England & Wales | (ii) | 2009-10 | 149 949 | 2009-10 | 225 844 | |||||
UK-Scotland | 2006 | 22 224 | 2010 | (UK) 127 893 | : | : | 225 844 | (UK) 40 988 182 | ||
UK-Northern Irel. | 2009-10 | 543 | 2009-10 | 2 518 | ||||||
Croatia | (iii) | 2010 | 5 035 | 2010 | 7 550 | 2010 | 7 550 | 7 550 | 2 972 315 | |
Turkey | (iii) | 2010 | : | 2010 | 2 900 | 2010 | 2 659 | (15) | 2 900 | 48 618 564 |
Norway | (iii) | 2010 | 6 015 | 2010 | 8 750 | 2010 | 8 750 | 8 750 | 3 217 801 |
Where data are not available for a country, the table entry is left empty.
(i) indicates that the clients considered to calculate the total estimation have been the substitution clients.
(ii) indicates that the clients considered to calculate the total estimation have been the total number of clients in treatment (ST24).
(iii) indicates that the clients considered to calculate the total estimation have been the all treatment demand clients (TDI).
See the data on number of clients in substitution treatment in Table HSR-3 part (i) .
See treatment demand data in Table TDI-2 part (ii) .
(1) Clients who have been in treatment because of opioid problem use (4000), cocaine or amphetamine problem use (200), including an estimate of the number of treated persons for hallucinogens, sedatives or cannabis (200).
(2) The information refers to all clients treated in 2009 for problems with illegal substances in outpatient healthcare facilites (2010 National Report; table 5-3: Number of clinics and number of addictive substance users treated in 2000-2009 (Nechanská et al. 2010; Institute of Health Information and Statistics, 2010a). This figure is an under-estimate as it only refers to clients being treated within these types of facilites and not all available treatment providers in the Czech Republic.
(3) No control for double-counting beyond centre level, estimates based on selected types of specialised treatment centres and extrapolated based on coverage estimates. Outpatient calculation based on 54.385 clients (no individual data, based on "last episode in a given year in a given centre" related to opiate-related disorders (F11.x), all treatments); inpatient calculation based on clients having ended a treatment episode in a given year. Additional source of information: 31.496 hospital treatments due to F11, unclear overlap with specialised treatment centres (estimates based on data from specialised outpatient treatment: 12.6-16.2% parallel treatment in discharge to hospitals). Additional source of information based on national substitution register: 77.400 registered clients in substitution treatment (for 34.6% of clients treated in outpatient specialised centres and 3.2% of inpatient clients, a parallel "substitution treatment" is recorded by treatment centres). Inpatient data was corrected by estimate
(4) Each case (episode) sought treatment for problem (illicit)drug use (excluding those who reported alcohol, hypnotic or sedatives as their main problem drug). The cases include those who reported one of the following as their main problem drug: an opiate, cocaine, a stimulant, hallucinogens, volatile inhalants and cannabis.
(5) The above data come from 68 officially recognized centres which offered treatment services in 2010 and delivered relevant data. They consist of 38 drug-free treatment programmes (of which 11 inpatient programmes for adults, 13 outpatient programmes for adults and 14 outpatient programmes for adolescents/young adults), 22 substitution treatment units (of which 6 methadone substitution units and 16 buprenorphine substitution units), 6 drug-free treatment programmes in prison and 1 outpatient detoxification program. The data collection is based on the Treatment Questionnaire” (2010), which is a revised version of the Treatment Unit Form/TUF A”. The collected information is controlled annually to check internal consistency. The figure does not include readmissions within the year in the same unit; whereas clearance for double entries among different units is not feasible.
(6) 90000 is the estimated number of patients who sought help in the outpatient treatment centers in 2008 for their problem with illegal drugs. Approximately 2000 people were accommodated in residential treatment centers and 4700 were welcomed for problems with illegal drugs in penal establishments in 2008. These numbers are estimates obtained from the activity reports sent by treatment centers once a year. About 90% of treatment centers provide these reports.
(7) Data refers to clients of the public drug outpatient treatment services (Ser.T.) in the year 2010.The total number of individual clients refers to clients who received treatment by Ser.T. for their drug problem. The clients can be treated in Ser.T. (outpatient service), in therapeutic communities (inpatient service) or in prison. The total number of treatment episodes refers to pharmacologically and/or psychosocial treatment performed by Ser.T. for clients who have drug problems. The clients can be treated in Ser.T. (outpatient service), in therapeutic communities (inpatient service) or in prison.
(8) The total number of persons in treatment in 2010 is controlled for double counts (clients entering treatment in the reporting year and those in treatment during the reporting year who had continued treatment from the previous year/s).
(9) All out-patient treatment clients according to Health Insurance Data, for which data in TDI (PREDA database) were reported. According to the Health Insurance Data additional 986 individual clients were treated in 2010 but were not reported in TDI.
(10) Data refers to opiates, amphetamines and cocaine users in treatment in 2009.
(11) Data come from the reporting system conducted by Institute of Psychiatry and Neurology covering only residential treatment due to mental and behavioural disorders caused by using illicit drugs. The residential system of statistical reporting is based on individual statistical questionnaires. Each questionnaire is coded. It is possible to eliminate double counting of persons who enter treatment several times a year, sometimes in many facilities.
(12) Individuals within at least one treatment episode during the reporting year. Includes: Opiates, Cocaine, stimulants, hypnotics and sedatives, hallucinogens,volatile and cannabis.
(13) Data sources: treatment centres under coordination of Ministry of Health, NAA, private centres and prisons. However not all centres (which are under coordination of Ministry of Health) have reported.
(14) Data source: TDI database.
(15) Inpatient data. All illlicit drug users included, volatile inhalants excluded.
See also 'General notes for interpreting data' on the Explanatory notes and help page.
Standard Tables 24 (ST24) on 'treatment availability' submitted by NFPs in 2011.
Standard Table 34 (TDI): Characteristics of individuals starting treatment for drugs by type of treatment centre submitted by NFPs in 2011.
Reitox National Reports 2011.
Eurostat for the demographic data.
Page last updated: Monday, 09 July 2012